510(k) Report

De Novo · Granted

Granted

ImPACT Computerized Neurocognitive Concussion Management Aid

DEN150037De NovoGranted Aug 22, 2016377-day reviewClass II21 CFR 882.1471

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Impact Applications, Inc. · POM Computerized Cognitive Assessment Aid For Concussion

Granted on Aug 22, 2016 as a new device type through De Novo after a 377-day review. 7 later devices descend from it.

Decided
Aug 22, 2016
Review
377 days
Class
Class II
Product code
POM
Recalls
None

7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2017: 2 descendants cleared2021: 1 descendant cleared2018: 1 descendant cleared2025: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant cleared201620182020202220242026
  1. This deviceDEN150037 ImPACT Computerized Neurocognitive Concussion Management AidImpact Applications, Inc. · 2016
  2. Descendant · cites it directly · 3 of its ownK170209 ImPACTImpact Applications, Inc. · 2017
  3. Descendant · 2 generations on · 2 of its ownK181223 ImPACTImpact Applications, Inc. · 2018
  4. Descendant · 3 generations on · 1 of its ownK202485 ImPACT Version 4Impact Applications, Inc. · 2020
  5. Descendant · cites it directly · 1 of its ownK170551 ImPACT Quick TestImpact Applications, Inc. · 2017
  6. Descendant · 2 generations on · 0 of its ownK241737 Sway System Sports PlusSway Medical, Inc. · 2025

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2017: 22018: 12020: 12021: 12023: 12025: 1
2017high 2 (2017) · low 0 (2019)2026

Most influential descendants

Showing 5 of 7 · See all
  • K170209ImPACTImpact Applications, Inc. · 2017 · cites it directly3descendants
  • K181223ImPACTImpact Applications, Inc. · 2018 · 2 generations on2descendants
  • K202485ImPACT Version 4Impact Applications, Inc. · 2020 · 3 generations on1descendant
  • K170551ImPACT Quick TestImpact Applications, Inc. · 2017 · cites it directly1descendant
  • K241737Sway System Sports PlusSway Medical, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN150037ImPACT Computerized Neurocognitive Concussion Management AidImpact Applications, Inc.2016—
+1K170209ImPACTImpact Applications, Inc.2017—
+2K181223ImPACTImpact Applications, Inc.2018—
+3K202485ImPACT Version 4Impact Applications, Inc.2020—
+1K170551ImPACT Quick TestImpact Applications, Inc.2017—
+2K241737Sway System Sports PlusSway Medical, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201720
201810
202010
202110
202310
202510
FIG. 1 — Lineage of DEN150037, 2016–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in POM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new POM device

  1. #1 K241737 Sway System Sports Plusscore 9.2 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170209ImPACTImpact Applications, Inc.20173
K170551ImPACT Quick TestImpact Applications, Inc.20171
K201376ANAM Test SystemVista Lifesciences, Inc.20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K170209 (Impact Applications, Inc., 2017) has gone furthest, with 3 descendants of its own.

How does its category compare?

All POM devices

POM Computerized Cognitive Assessment Aid For Concussion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · POM

1in 2025

2016: 12017: 22018: 12020: 12021: 12023: 12025: 12026 (partial year): 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · POM

Too few POM 510(k)s in any year since 2007 to give a median.

Recalls per year · POM

No recall names POM since 2007.

Adverse event reports per year · POM

No MAUDE report names POM since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20161—00
20172—00
20181—00
20190—00
20201—00
20211—00
20220—00
20231—00
20240—00
20251—00
20261—0—

What is it indicated for?

ImPACT is intended for use as a computer-based neurocognitive test battery to aid in the assessment and management of concussion. ImPACT is a neurocognitive test battery that provides healthcare professionals with objective measure of neurocognitive functioning as an assessment aid and in the management of concussion in individuals ages 12-59. ImPACT Pediatric is intended for use as a computer-based neurocognitive test battery to aid in the assessment…

Read the full statement (102 words)

ImPACT is intended for use as a computer-based neurocognitive test battery to aid in the assessment and management of concussion.

ImPACT is a neurocognitive test battery that provides healthcare professionals with objective measure of neurocognitive functioning as an assessment aid and in the management of concussion in individuals ages 12-59.

ImPACT Pediatric is intended for use as a computer-based neurocognitive test battery to aid in the assessment and management of concussion.

ImPACT Pediatric is a neurocognitive test battery that provides healthcare professionals with objective measure of neurocognitive functioning as an assessment aid and in the management of concussion in individuals ages 5-11.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN150037: ImPACT Computerized Neurocognitive Concussion Management Aid.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/DEN150037

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026